Format

Send to

Choose Destination
Biomed Res Int. 2017;2017:1634801. doi: 10.1155/2017/1634801. Epub 2017 Jun 12.

"mTOR Signaling Pathway": A Potential Target of Curcumin in the Treatment of Spinal Cord Injury.

Author information

1
Department of Histology and Embryology, Medical College, Shaoxing University, Zhejiang, China.
2
Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, China.

Abstract

The purpose of this review is to discuss the possibility of the treatment of spinal cord injury (SCI) with curcumin via regulating the mTOR signaling pathway, which may provide another strong support for curcumin to be a promising medicine applied to the treatment of SCI. Curcumin is termed as a multifunctional targeting therapy drug that regulates the mTOR signaling pathway in the treatment of numerous diseases. Previous research has already revealed that mTOR signaling pathway plays a vital role in prognosis, which involves the axon regeneration and autophagy. This review discusses a potential mechanism that curcumin suppresses the activation of this pathway and ameliorates the microenvironment of axons regeneration which would provide a new way that induces autophagy appropriately.

PMID:
28691015
PMCID:
PMC5485291
DOI:
10.1155/2017/1634801
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center